References
- Simonneau G, Galie N, Rubin LJ, et al. Clinical classification of pulmonary hypertension. J Am Coll Cardiol 2004;43:5S–12
- Humbert M, Sitbon O, Simonneau G. Treatment of pulmonary arterial hypertension. N Engl J Med 2004;351:1425–36
- Kerstein D, Levy PS, Hsu DT, et al. Blade balloon atrial septostomy in patients with severe primary pulmonary hyper-tension. Circulation 1995;91:2028–35
- Sandoval J, Gaspar J, Pulido T, et al. Graded balloon dilation atrial septostomy in severe primary pulmonary hypertension. J Am Coll Cardiol 1998;32:297–304
- Sandoval J, Rothman A, Pulido T. Atrial septostomy for pulmonary arterial hypertension. Clin Chest Med 2001;22: 547–60
- Humbert M, Sitbon O, Chaouat A, et al. Pulmonary arterial hypertension in France: results from a national registry. Am J Respir Crit Care Med 2006;173:1023–30
- Sandoval J, Bauerle O, Gomez A, et al. Primary pulmonary hypertension in children: clinical characterization and survival. J Am Coll Cardiol 1995;25:466–74
- Hopkins WE, Waggoner AD. Severe pulmonary hypertension without right ventricular failure: the unique heart of patients with Eisenmenger syndrome. Am J Cardiol 2002;89: 34–8
- Mikhail GW, Gibbs SR, Yacoub MH. Pulmonary and systemic arterial pressure changes during syncope in primary pulmonary hypertension. Circulation 2001;104:1326–7
- Amin Z, Danford DA, Pedra CA. A new Amplatzer device to maintain patency of Fontan fenestrations and atrial septal defects. Catheter Cardiovasc Interv 2002;57:246–51
- Micheletti A, Hislop A, Lammers A, et al. Role of atrial septostomy in the treatment of children with pulmonary arterial hypertension. Heart 2006;92:969–72
- Austen WG, Morrow AG, Berry WB. Experimental studies of the surgical treatment of primary pulmonary hypertension. J Thorac Cardiovasc Surg 1964;48:448–55
- Barst RJ, Maislin G, Fishman AP. Vasodilator therapy for primary pulmonary hypertension in children. Circulation 1999;99:1197–208
- Sitbon O, Humbert M, Nunez H, et al. Long-term intravenous epoprostenol infusion in primary pulmonary hypertension: prognostic factors and survival. J Am Coll Cardiol 2002;40: 780–8
- Humbert M, Barst RJ, Robbins IM, et al. Combination of bosentan with epoprostenol in pulmonary arterial hypertension: BREATHE-2. Eur Respir J 2004;24:353–9